More Press Releases

View Older Stories View Newer Stories

Nov 3, 2026 04:40PM Cutaneous Lupus Erythematosus Pipeline Analysis 2026: Phase III and Phase II Assets, MOA Breakdown, and ROA Trends | Biogen, Horizon Therapeutics, Bristol–Myers Squibb, AstraZeneca, Sanofi, Amgen
Nov 3, 2026 04:40PM Mantle Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Nov 3, 2026 04:40PM What’s Fueling the Ovarian Cancer Market Boom? Industry to Cross USD 5.7 Billion by 2034 | pharma& GmbH, GlaxoSmithKline, Verastem Oncology, Daiichi Sankyo, AstraZeneca, ProfoundBio, Genmab, Tesaro
Nov 3, 2026 04:39PM One World Chain Launches EVM-Compatible Layer 1 Blockchain and Activates Native OWCT Asset
Nov 3, 2026 04:39PM Kadant Reports Third Quarter 2026 Results
Nov 3, 2026 04:38PM MotorWeek announces streaming deal with DRIVEN
Nov 3, 2026 04:35PM Glucagon-Like Peptide Agonist Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Nov 3, 2026 04:35PM AM Best Revises Outlooks to Positive for Funeral Directors Life Insurance Company
Nov 3, 2026 04:33PM JELD-WEN Reports Third Quarter 2026 Results
Nov 3, 2026 04:33PM Toufayan Bakeries Introduces "Simply Sourdough Pita"
Nov 3, 2026 04:31PM IGT and MGM Springfield Launch First Wide-Area Progressive Jackpot Games in Massachusetts
Nov 3, 2026 04:30PM Amdocs Limited Reports Fourth Quarter Fiscal 2026 Results & Full Year Fiscal 2026 Results
Nov 3, 2026 04:30PM Synovial Sarcoma Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Nov 3, 2026 04:30PM Anterior Cruciate Ligament Injuries Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Nov 3, 2026 04:30PM Post-Traumatic Stress Disorder Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Nov 3, 2026 04:30PM Autism Spectrum Disorder Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Nov 3, 2026 04:30PM Radiotherapy Induced Oral Mucositis Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
Nov 3, 2026 04:30PM NCLA Asks Court to End WA Dept. of Fish and Wildlife’s Illegal 24-Hour Surveillance of Crab Boats
Nov 3, 2026 04:30PM Bristow Group Reports Third Quarter 2026 Results
Nov 3, 2026 04:30PM Intrepid Announces Third Quarter 2026 Results
Nov 3, 2026 04:30PM Dauch Corporation Announces Employee Inducement Award Under NYSE Rule 303A.08
Nov 3, 2026 04:30PM Viking Therapeutics to Participate at Upcoming Investor Conferences
Nov 3, 2026 04:30PM Tronox Declares Fourth Quarter 2026 Dividend
Nov 3, 2026 04:30PM GeoPark Reports Third Quarter 2026 Results
Nov 3, 2026 04:30PM Vanda Pharmaceuticals Announces Participation at November 2026 Investor Conferences
Nov 3, 2026 04:30PM Everus Reports Third Quarter 2026 Results, Raises 2026 Guidance
Nov 3, 2026 04:30PM Hormel Foods Corporation Announces Fourth Quarter Earnings Call
Nov 3, 2026 04:30PM Limbach Reports Third Quarter 2026 Results
Nov 3, 2026 04:30PM SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2026 RESULTS
Nov 3, 2026 04:30PM WhiteFiber Completes Acquisition of Two North Carolina Data Center Development Sites and Provides NC-1 Update
Nov 3, 2026 04:30PM Solstice Advanced Materials Declares Dividend of $0.075 per Common Share
Nov 3, 2026 04:30PM Verra Mobility Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Nov 3, 2026 04:30PM X4 Pharmaceuticals to Participate in Guggenheim, Stifel, and Jefferies Conferences in November 2026
Nov 3, 2026 04:30PM XMax Inc. Announces Preliminary Third Quarter 2026 Financial Results
Nov 3, 2026 04:30PM Kevin Sayer Joins Guardant Health Board of Directors
Nov 3, 2026 04:30PM Melcor Developments announces third quarter results, declares quarterly dividend of $0.15 per share
Nov 3, 2026 04:30PM State Street Corporation (NYSE: STT) Announces 2027 Quarterly Financial Results Release Dates
Nov 3, 2026 04:30PM VSE Corporation Declares Quarterly Cash Dividend
Nov 3, 2026 04:30PM Silgan Declares Quarterly Dividend
Nov 3, 2026 04:30PM Teamshares Management to Present at Roth Technology Conference
Nov 3, 2026 04:30PM Travere Therapeutics to Participate at Upcoming Investor Conferences
Nov 3, 2026 04:30PM GXO Reports Third Quarter 2026 Results
Nov 3, 2026 04:30PM Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 3, 2026 04:30PM Xilio Therapeutics to Present at the Stifel 2026 Healthcare Conference
Nov 3, 2026 04:28PM Power Knot Congratulates Coral Beach Resort Sharjah on Sustain Sharjah Award
Nov 3, 2026 04:28PM Elevar Therapeutics Announces Lirafugratinib (Lyrfigtu) Added to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) as Second-line Therapy for Cholangiocarcinoma with FGFR2 Fusion or Othe
Nov 3, 2026 04:28PM AGENT Unveils Coordinated Multi-Agent AI System and Sets December 1 Start for AGENT Token Community Presale
Nov 3, 2026 04:28PM Tidewater Announces Earnings Release and Conference Call
Nov 3, 2026 04:27PM Consumers Energy Provides State Regulators More Time to Approve Sale of 13 Michigan Dams
Nov 3, 2026 04:25PM Amyloidosis Market is Projected to Boom by 2036 Owing to the Advancement of Novel Therapies and Increasing Disease Awareness | DelveInsight
View Newer Stories View Older Stories